Results 201 to 210 of about 25,487 (235)
Some of the next articles are maybe not open access.
Fundamental & Clinical Pharmacology, 2003
AbstractIvermectin, a parasiticide that long ago proved its worth in veterinary medicine, became one of the most effective tools for control programs against human filarial diseases in the 1980s. It is provided at no cost, is effective against microfilariae (blocking their transmission) and can be administered annually as a single oral dose with ...
P. Gaxotte +2 more
openaire +3 more sources
AbstractIvermectin, a parasiticide that long ago proved its worth in veterinary medicine, became one of the most effective tools for control programs against human filarial diseases in the 1980s. It is provided at no cost, is effective against microfilariae (blocking their transmission) and can be administered annually as a single oral dose with ...
P. Gaxotte +2 more
openaire +3 more sources
Annales de Dermatologie et de Vénéréologie, 2004
Ivermectin is a semi-synthetic derivative of a macrocyclic lactone. It causes paralysis in many nematodes and arthropodes because of its effect on ion-channels in cell membranes. Ivermectin was first used in veterinary medicine. In man, it was shown to be microfilaricid against Onchocerca volvulus. Most of the adverse reactions following treatment were
openaire +2 more sources
Ivermectin is a semi-synthetic derivative of a macrocyclic lactone. It causes paralysis in many nematodes and arthropodes because of its effect on ion-channels in cell membranes. Ivermectin was first used in veterinary medicine. In man, it was shown to be microfilaricid against Onchocerca volvulus. Most of the adverse reactions following treatment were
openaire +2 more sources
Current Opinion in Infectious Diseases, 2002
The standard treatment for scabies has long been based on topical scabicides. Ivermectin, a broad-spectrum anti-parasitic agent, was first used in veterinary medicine. This drug, active against nematodes and arthropods, is used in humans for the treatment of filariasis.
openaire +3 more sources
The standard treatment for scabies has long been based on topical scabicides. Ivermectin, a broad-spectrum anti-parasitic agent, was first used in veterinary medicine. This drug, active against nematodes and arthropods, is used in humans for the treatment of filariasis.
openaire +3 more sources
Trends in Parasitology, 2015
In September, Trends in Parasitology published two articles related to the discovery of ivermectin and the acknowledgement of Dr Satoshi Omura receiving the 2014 Gairdner Global Health Award for his contribution. Although Dr Omura isolated the avermectin-producing microorganism Streptomyces avermitilis, many other scientists and researchers contributed
Hugh R. Taylor, David H. Molyneux
openaire +2 more sources
In September, Trends in Parasitology published two articles related to the discovery of ivermectin and the acknowledgement of Dr Satoshi Omura receiving the 2014 Gairdner Global Health Award for his contribution. Although Dr Omura isolated the avermectin-producing microorganism Streptomyces avermitilis, many other scientists and researchers contributed
Hugh R. Taylor, David H. Molyneux
openaire +2 more sources
Parasitology Today, 1985
Ivermecan was introduced as an antiparasitic agent in 1981. It is now registered for animal-health use in 35 countries and is being evaluated for possible use in man. This review summarises its antiparasitic efficacy and apparent mode of action. Additional information is given in previous review articles.
openaire +3 more sources
Ivermecan was introduced as an antiparasitic agent in 1981. It is now registered for animal-health use in 35 countries and is being evaluated for possible use in man. This review summarises its antiparasitic efficacy and apparent mode of action. Additional information is given in previous review articles.
openaire +3 more sources
Parasitology Today, 1993
In this review of ivermectin resistance, Wesley Shoop discusses the definition of resistance, catalogs all known cases of ivermectin resistance, argues that overmectins and milbemycins belong in the same action family, discusses the possibility of resistance in the filariae, and suggests that detection of ivermectin resistance is the area where future ...
openaire +2 more sources
In this review of ivermectin resistance, Wesley Shoop discusses the definition of resistance, catalogs all known cases of ivermectin resistance, argues that overmectins and milbemycins belong in the same action family, discusses the possibility of resistance in the filariae, and suggests that detection of ivermectin resistance is the area where future ...
openaire +2 more sources
Journal of Prescribing Practice, 2021
George Winter examines the ongoing discussion as to whether invermectin can be used in the treatment of COVID-19, breaking down opposing viewpoints, the integrity of research, and the need for further analysis
openaire +1 more source
George Winter examines the ongoing discussion as to whether invermectin can be used in the treatment of COVID-19, breaking down opposing viewpoints, the integrity of research, and the need for further analysis
openaire +1 more source
Ivermectin: A Review in Rosacea [PDF]
American Journal of Clinical Dermatology, 2015 Ivermectin 1% cream (Soolantra(®); Rosiver™; Izefla(®)) is a novel topical agent indicated for the once-daily treatment of inflammatory lesions of rosacea. Ivermectin is a derivative of the avermectin family of macrocyclic lactone parasiticides. It displays anti-inflammatory properties as well as broad-spectrum anti-parasitic activity, both of which ...
openaire +2 more sources
Review of Ivermectin in Scabies
Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology, 2001Background: Currently available topical medications for scabies are messy and need prolonged application. This leads to poor patient adherence. Emerging drug resistance to topical scabicides has made eradication of scabies difficult. Objective: Availability of an effective oral scabicidal agent, ivermectin (Ivm), opens a new era in the management of ...
openaire +3 more sources
Coagulation abnormalities and ivermectin
Annals of Tropical Medicine & Parasitology, 1992Prothrombin ratios were measured 13-16 days after treatment in 148 subjects from Sierra Leone taking part in a double-blind placebo-controlled trial of ivermectin. Prolonged prothrombin ratios were observed more frequently in the ivermectin group, although this difference was not significant and no patients suffered bleeding complications.
D. W. Taylor +5 more
openaire +3 more sources